$CRMZ
CREDITRISKMONITOR COM INC

2024 Q4 Form 10-Q Financial Statement

#000114036124046898 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $5.009M
YoY Change 4.52%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.257M
YoY Change -7.48%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $4.560M
YoY Change 1.64%
Operating Profit $449.3K
YoY Change 46.75%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $267.1K
YoY Change 42.01%
Pretax Income $716.3K
YoY Change 44.94%
Income Tax $164.8K
% Of Pretax Income 23.0%
Net Earnings $551.6K
YoY Change 45.66%
Net Earnings / Revenue 11.01%
Basic Earnings Per Share $0.05
Diluted Earnings Per Share $0.05
COMMON SHARES
Basic Shares Outstanding 10.72M 10.72M
Diluted Shares Outstanding 10.77M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $7.888M
Short-Term Investments
Other Short-Term Assets $916.3K
YoY Change -15.23%
Inventory
Prepaid Expenses
Receivables $3.566M
Other Receivables
Total Short-Term Assets $14.85M
YoY Change -22.59%
LONG-TERM ASSETS
Property, Plant & Equipment $544.1K
YoY Change 9.37%
Goodwill $1.954M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $18.11K
YoY Change 0.0%
Total Long-Term Assets $10.88M
YoY Change 163.12%
TOTAL ASSETS
Total Short-Term Assets $14.85M
Total Long-Term Assets $10.88M
Total Assets $25.73M
YoY Change 10.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $72.89K
YoY Change -24.18%
Accrued Expenses $2.397M
YoY Change 0.51%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $13.55M
YoY Change 7.93%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $13.55M
Total Long-Term Liabilities
Total Liabilities $15.48M
YoY Change 6.24%
SHAREHOLDERS EQUITY
Retained Earnings -$19.94M
YoY Change -6.55%
Common Stock $107.2K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $10.25M
YoY Change
Total Liabilities & Shareholders Equity $25.73M
YoY Change 10.33%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $551.6K
YoY Change 45.66%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
30000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
14852351
CY2024Q3 us-gaap Goodwill
Goodwill
1954460
CY2023Q4 us-gaap Goodwill
Goodwill
1954460
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
18110
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
9367886
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
716346
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
115552
us-gaap Operating Income Loss
OperatingIncomeLoss
387768
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1442581
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
337273
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
22329
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
9367886
us-gaap Share Based Compensation
ShareBasedCompensation
73892
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-69066
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
10249953
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
788722
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
544097
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
557634
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
168073
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
32500000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10722401
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10722401
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10722401
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10722401
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
107224
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
107224
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
30081665
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
30007773
us-gaap Net Income Loss
NetIncomeLoss
808175
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
278039
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
148259
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5326358
CY2024Q3 us-gaap Revenues
Revenues
5009370
CY2023Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1951360
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2256732
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2439147
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
97513
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
96216
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
4560116
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
449254
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
306146
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
267092
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
188083
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
494229
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
164764
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
551582
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
378677
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10722401
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10770383
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10799481
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7505751
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7050702
us-gaap Depreciation And Amortization
DepreciationAndAmortization
291576
us-gaap Depreciation And Amortization
DepreciationAndAmortization
288303
us-gaap Operating Expenses
OperatingExpenses
14364077
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.1
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10722401
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10764587
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
9672092
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
26279
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3116904
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1221405
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25730566
CY2023Q3 us-gaap Revenues
Revenues
4792869
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10722401
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10801243
us-gaap Share Based Compensation
ShareBasedCompensation
75853
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
434901
CY2024Q3 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
2481973
CY2023Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
3494958
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
30000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3566066
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3941182
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
18110
CY2024Q3 us-gaap Assets
Assets
25730566
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
211488
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2396638
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2105019
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
13550671
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12730815
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
350605
CY2024Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
194959
CY2023Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
68523
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1384378
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1554686
CY2024Q3 us-gaap Liabilities
Liabilities
15480613
CY2023Q4 us-gaap Liabilities
Liabilities
14704629
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
32500000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19938936
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24072515
us-gaap Net Income Loss
NetIncomeLoss
1105308
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-146697
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-121798
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
8735
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-375116
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-630732
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
127557
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2209454
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1368405
us-gaap Proceeds From Sale Of Held To Maturity Securities
ProceedsFromSaleOfHeldToMaturitySecurities
2850000
us-gaap Proceeds From Sale Of Held To Maturity Securities
ProceedsFromSaleOfHeldToMaturitySecurities
3630000
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
7898319
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
3628741
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11004937
CY2024Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
10855818
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
10272352
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
72890
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
141956
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
225325
CY2024Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
350605
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
4486723
us-gaap Revenues
Revenues
14751845
us-gaap Revenues
Revenues
14066112
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
6566750
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
5806156
us-gaap Operating Expenses
OperatingExpenses
13145161
us-gaap Operating Income Loss
OperatingIncomeLoss
920951
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
664587
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
521630
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1052355
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
244180
us-gaap Net Income Loss
NetIncomeLoss
808175
us-gaap Net Income Loss
NetIncomeLoss
1105308
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.1
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
551582
us-gaap Depreciation And Amortization
DepreciationAndAmortization
291576
us-gaap Depreciation And Amortization
DepreciationAndAmortization
288303
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2494
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
709902
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-202185
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-149715
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
291619
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9866628
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7888033
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11088033
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1453548
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1612512
CY2024Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
2205871
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
8349890
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
8750896
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
10249953
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
7569735
us-gaap Net Income Loss
NetIncomeLoss
1105308
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
75853
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
8750896
us-gaap Net Income Loss
NetIncomeLoss
808175
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
73892
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-147000
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
916279
CY2023Q4 us-gaap Assets Current
AssetsCurrent
19229799
CY2024Q3 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
6908000
CY2023Q4 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
700000
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7888033
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11004937
CY2023Q4 us-gaap Assets
Assets
24072515
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-20747111
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
10249953
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10722401
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
378677
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0000315958
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
1-8601
dei Entity Registrant Name
EntityRegistrantName
CreditRiskMonitor.com, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
36-2972588
dei Entity Address Address Line1
EntityAddressAddressLine1
704 Executive Boulevard
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite A
dei Entity Address City Or Town
EntityAddressCityOrTown
Valley Cottage
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10989
dei City Area Code
CityAreaCode
845
dei Local Phone Number
LocalPhoneNumber
230-3000
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10722401
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
26279
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
22329
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
73892
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
75853
CY2024Q3 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
91220
CY2024Q3 us-gaap Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
2481973
CY2024Q3 crmz Held To Maturity Securities Debt Maturities After One Through Two Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughTwoYearsNetCarryingAmount
6908000
CY2024Q3 us-gaap Held To Maturity Securities Debt Maturities Single Maturity Date Amortized Cost Basis
HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
9389973
crmz Other Than Temporary Impairment Loss Debt Securities Held To Maturity Before Tax
OtherThanTemporaryImpairmentLossDebtSecuritiesHeldToMaturityBeforeTax
0
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10722401
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10722401
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10722401
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10722401
CY2024Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
255500
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
311950
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
257133
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
320697
CY2024Q3 us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
207518
CY2023Q3 us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
234870
us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
214947
us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
241855
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10770383
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10799481
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10764587
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10801243
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
155700

Files In Submission

Name View Source Status
0001140361-24-046898-index-headers.html Edgar Link pending
0001140361-24-046898-index.html Edgar Link pending
0001140361-24-046898.txt Edgar Link pending
0001140361-24-046898-xbrl.zip Edgar Link pending
crmz-20240930.xsd Edgar Link pending
ef20034558_10q.htm Edgar Link pending
ef20034558_ex31-1.htm Edgar Link pending
ef20034558_ex31-2.htm Edgar Link pending
ef20034558_ex32-1.htm Edgar Link pending
ef20034558_ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
crmz-20240930_def.xml Edgar Link unprocessable
crmz-20240930_lab.xml Edgar Link unprocessable
crmz-20240930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ef20034558_10q_htm.xml Edgar Link completed
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
crmz-20240930_cal.xml Edgar Link unprocessable